Hyperectumine (1), the first C19 benzylisoquinoline alkaloid with a complicated ring system, was isolated from Hypecoum erectum and structurally characterized. Its biosynthetic origin should involve a hybrid pattern of C8 + C8 + C1 + C2, from which a C17 benzylisoquinoline alkaloid might be further attacked by a malonamic acid and undergo decarboxylation and cyclization to produce 1. Compound (-)-1 exhibited moderate anti-inflammatory activity via suppression of LPS-activated inflammatory mediators in RAW 264.7 macrophage cells.

Hyperectumine, a C19 benzylisoquinoline alkaloid with a complex ring system, exhibits moderate anti-inflammatory activity by suppressing LPS-activated inflammatory mediators in RAW 264.7 macrophage cells.

Paper

C19 Benzylisoquinoline Alkaloid with Unprecedented Architecture from Hypecoum erectum.

References

Citations